PharmiWeb.com - Global Pharma News & Resources
20-Jun-2019

Immunoassay Market Size is Projected to Jump US$ 26.1 Bn by 2026

Global Immunoassay Market Size is expected to reach USD 26.1 Billion by 2026 and growing CAGR around 4.9 % during the forecast period.

The Global Immunoassay Market studies the overall dynamics and trends of the market in terms of various segments and regional outlook for the period of 2018 to 2026. The report offers of historic and future market scenario in terms of market value, share and critical developments taking place in the industry. Market size, forecast, trends of each country and region are studied in the report for the focus period of 2018 to 2026.

Request a Sample Copy of this Research Report at https://www.acumenresearchandconsulting.com/request-sample/1277

Qualitative assessment tools such as PEST analysis, cost structure analysis and regulatory compliance for pharmaceutical products are offered in the report. The report also comprises Pipeline Analysis which helps understand the comprehensive forecast scenario of the market in terms of value and dynamics. The report analyses the recent drug approval trends and market dynamics such as drivers, restrains, and opportunities, industry trends and future outlook in the global Immunoassay Market.

Key Takeaways:

  • What is the market size in 2018 and the growth rate of the global Immunoassay Market?
  • What is the market drivers, restrains, opportunities governing the global Immunoassay Market?
  • Which is the largest and the fastest growing segments in the global Immunoassay Market?
  • Who are the key players operating in the market and their market position?
  • What is the pipeline scenario, drug pricing analysis and technological development in the market?

Market Players:

The report represents key players operating in the market along with its competitive landscape. The competitive landscape includes player positioning analysis, competitive matrix and market share analysis of the key players operating in the industry. The market attractive index highlights the most lucrative regional market to invest in the market. The Immunoassay Market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are Dickinson amp; Company; Becton, Thermo Fisher Scientific, Inc.; BioMeacute;rieux; Siemens Healthineers; Abbott Laboratories; Roche Diagnostics; Sysmex Corporation; Danaher Corporation; Ortho-Clinical Diagnostics; and Quidel Corporation.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1277

The Major Market Segments of GlobalImmunoassay Marketare as below:

Market Segmentation

Market by Technology

  • Enzyme Immunoassay (EIA)
    • Fluorescence Immunoassays (FIA)
    • Chemiluminescence Immunoassays (CLIA)
  • Radioimmunoassay (RIA)
  • Rapid test
  • Others

Market by Product

  • Analyzers/instruments
    • Closed ended systems
    • Open ended systems
  • Reagents amp; kits
  • Software amp; services

Market by Application

  • Endocrinology
  • Therapeutic drug monitoring
  • Autoimmune diseases
  • Infectious disease testing
  • Cardiology
  • Others

Market by End-Use

  • Hospitals
  • Pharmaceutical and biotech companies
  • Clinical laboratories
  • Academic research centers
  • Blood banks
  • Others

Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on Immunoassay Market (By Technology: Enzyme Immunoassay (EIA) [Fluorescence Immunoassays (FIA), Chemiluminescence Immunoassays (CLIA)], Radioimmunoassay (RIA), Rapid test, Others; By Product: Analyzers/instruments [Closed ended systems, Open ended systems], Reagents amp; kits, Software amp; services; By Application: Endocrinology, Therapeutic drug monitoring, Autoimmune diseases, Infectious disease testing, Cardiology, Others; By End-Use: Hospitals, Pharmaceutical and biotech companies, Clinical laboratories, Academic research centers, Blood banks, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026offers detailed insights on global Immunoassay market segments with market dynamics and their impact.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Immunoassay
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Immunoassay Market By Technology
1.2.2.1. Global Immunoassay Market Revenue and Growth Rate Comparison By Technology (2015-2026)
1.2.2.2. Global Immunoassay Market Revenue Share By Technology in 2017
1.2.2.3. Enzyme Immunoassay (EIA)
1.2.2.3.1. Fluorescence Immunoassays (FIA)
1.2.2.3.2. Chemiluminescence Immunoassays (CLIA)
1.2.2.4. Radioimmunoassay (RIA)
1.2.2.5. Rapid test
1.2.2.6. Others
1.2.3. Immunoassay Market By Product
1.2.3.1. Global Immunoassay Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.3.2. Global Immunoassay Market Revenue Share By Product in 2017
1.2.3.3. Analyzers/instruments
1.2.3.3.1. Closed ended systems
1.2.3.3.2. Open ended systems
1.2.3.4. Reagents amp; kits
1.2.3.5. Software amp; services
1.2.3.6. Others
1.2.4. Immunoassay Market By Application
1.2.4.1. Global Immunoassay Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.4.2. Global Immunoassay Market Revenue Share By Application in 2017
1.2.4.3. Endocrinology
1.2.4.4. Therapeutic drug monitoring
1.2.4.5. Autoimmune diseases
1.2.4.6. Infectious disease testing
1.2.4.7. Cardiology
1.2.4.8. Others
1.2.5. Immunoassay Market By End-Use
1.2.5.1. Global Immunoassay Market Revenue and Growth Rate Comparison By End-Use (2015-2026)
1.2.5.2. Global Immunoassay Market Revenue Share By End-Use in 2017
1.2.5.3. Hospitals
1.2.5.4. Pharmaceutical and biotech companies
1.2.5.5. Clinical laboratories
1.2.5.6. Academic research centers
1.2.5.7. Blood banks
1.2.5.8. Others
1.2.6. Immunoassay Market by Geography
1.2.6.1. Global Immunoassay Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.6.2. North America Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.3. Europe Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.4. Asia-Pacific Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.5. Latin America Immunoassay Market Revenue and Growth Rate (2015-2026)
1.2.6.6. Middle East and Africa (MEA) Immunoassay Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Immunoassay Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Immunoassay Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Immunoassay Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Immunoassay Major Manufacturers in 2017

CHAPTER 4. Immunoassay Market By Technology

4.1. Global Immunoassay Revenue By Technology
4.2. Enzyme Immunoassay (EIA)
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Fluorescence Immunoassays (FIA)
4.2.4. Chemiluminescence Immunoassays (CLIA)
4.3. Radioimmunoassay (RIA)
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Rapid test
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Immunoassay Market By Product

5.1. Global Immunoassay Revenue By Product
5.2. Analyzers/instruments
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.2.3. Closed ended systems
5.2.4. Open ended systems
5.3. Reagents amp; kits
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Software amp; services
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Others
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. Immunoassay Market By Application

6.1. Global Immunoassay Revenue By Application
6.2. Endocrinology
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Therapeutic drug monitoring
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Autoimmune diseases
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Infectious disease testing
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.6. Cardiology
6.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.7. Others
6.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. Immunoassay Market By End-Use

7.1. Global Immunoassay Revenue By End-Use
7.2. Hospitals
7.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.3. Pharmaceutical and biotech companies
7.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.4. Clinical laboratories
7.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.5. Academic research centers
7.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.6. Blood banks
7.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
7.7. Others
7.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 8. North America Immunoassay Market By Country

8.1. North America Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. North America Immunoassay Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. U.S.
8.3.1. U.S. Immunoassay Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Canada
8.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. Mexico
8.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 9. Europe Immunoassay Market By Country

9.1. Europe Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Europe Immunoassay Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. UK
9.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Germany
9.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. France
9.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.6. Spain
9.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.7. Rest of Europe
9.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 10. Asia-Pacific Immunoassay Market By Country

10.1. Asia-Pacific Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Asia-Pacific Immunoassay Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. China
10.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. Japan
10.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. India
10.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.6. Australia
10.6.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.6.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.7. South Korea
10.7.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.7.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.8. Rest of Asia-Pacific
10.8.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
10.8.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 11. Latin America Immunoassay Market By Country

11.1. Latin America Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Latin America Immunoassay Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Brazil
11.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. Argentina
11.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Latin America
11.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 12. Middle East Immunoassay Market By Country

12.1. Middle East Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Middle East Immunoassay Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. Saudi Arabia
12.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.4. UAE
12.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
12.5. Rest of Middle East
12.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 13. Africa Immunoassay Market By Country

13.1. Africa Immunoassay Market Revenue and Growth Rate, 2015 - 2026 ($Million)
13.2. Africa Immunoassay Market Revenue Share Comparison, 2015 amp; 2026 (%)
13.3. South Africa
13.3.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.3.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
13.4. Egypt
13.4.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.4.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
13.5. Rest of Africa
13.5.1. Market Revenue and Forecast By Technology, 2015 - 2026 ($Million)
13.5.2. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 14. COMPANY PROFILE

14.1. Dickinson amp; Company
14.1.1. Company Snapshot
14.1.2. Overview
14.1.3. Financial Overview
14.1.4. Product Portfolio
14.1.5. Key Developments
14.1.6. Strategies
14.2. Becton
14.2.1. Company Snapshot
14.2.2. Overview
14.2.3. Financial Overview
14.2.4. Product Portfolio
14.2.5. Key Developments
14.2.6. Strategies
14.3. Thermo Fisher Scientific, Inc.
14.3.1. Company Snapshot
14.3.2. Overview
14.3.3. Financial Overview
14.3.4. Product Portfolio
14.3.5. Key Developments
14.3.6. Strategies
14.4. BioMeacute;rieux
14.4.1. Company Snapshot
14.4.2. Overview
14.4.3. Financial Overview
14.4.4. Product Portfolio
14.4.5. Key Developments
14.4.6. Strategies
14.5. Siemens Healthineers
14.5.1. Company Snapshot
14.5.2. Overview
14.5.3. Financial Overview
14.5.4. Product Portfolio
14.5.5. Key Developments
14.5.6. Strategies
14.6. Abbott laboratories
14.6.1. Company Snapshot
14.6.2. Overview
14.6.3. Financial Overview
14.6.4. Product Portfolio
14.6.5. Key Developments
14.6.6. Strategies
14.7. Roche Diagnostics
14.7.1. Company Snapshot
14.7.2. Overview
14.7.3. Financial Overview
14.7.4. Product Portfolio
14.7.5. Key Developments
14.7.6. Strategies
14.8. Sysmex Corporation
14.8.1. Company Snapshot
14.8.2. Overview
14.8.3. Financial Overview
14.8.4. Product Portfolio
14.8.5. Key Developments
14.8.6. Strategies
14.9. Danaher Corporation
14.9.1. Company Snapshot
14.9.2. Overview
14.9.3. Financial Overview
14.9.4. Product Portfolio
14.9.5. Key Developments
14.9.6. Strategies
14.10. Ortho Clinical Diagnostics
14.10.1. Company Snapshot
14.10.2. Overview
14.10.3. Financial Overview
14.10.4. Product Portfolio
14.10.5. Key Developments
14.10.6. Strategies
14.11. Quidel Corporation
14.11.1. Company Snapshot
14.11.2. Overview
14.11.3. Financial Overview
14.11.4. Product Portfolio
14.11.5. Key Developments
14.11.6. Strategies
14.12. Others
14.12.1. Company Snapshot
14.12.2. Overview
14.12.3. Financial Overview
14.12.4. Product Portfolio
14.12.5. Key Developments
14.12.6. Strategies

CHAPTER 15. RESEARCH APPROACH

15.1. Research Methodology
15.1.1. Initial Data Search
15.1.2. Secondary Research
15.1.3. Primary Research
15.2. Assumptions and Scope

To Purchase this Premium Report athttps://www.acumenresearchandconsulting.com/buy-now/0/1277

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 20-Jun-2019